Annexin A4 is a promising therapeutic target for the treatment of platinum-resistant cancers
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Annexin A4 is a promising therapeutic target for the treatment of platinum-resistant cancers
Authors
Keywords
-
Journal
EXPERT OPINION ON THERAPEUTIC TARGETS
Volume 18, Issue 4, Pages 403-414
Publisher
Informa Healthcare
Online
2014-01-30
DOI
10.1517/14728222.2014.882323
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Annexin A2 is regulated by ovarian cancer-peritoneal cell interactions and promotes metastasis
- (2015) Noor A. Lokman et al. Oncotarget
- Suppression of Annexin A11 in Ovarian Cancer: Implications in Chemoresistance
- (2015) Jin Song et al. NEOPLASIA
- Annexin A6 Interacts With p65 and Stimulates NF-κB Activity and Catabolic Events in Articular Chondrocytes
- (2013) Kirk A. Campbell et al. ARTHRITIS AND RHEUMATISM
- Overexpression of annexin A4 is associated with chemoresistance in papillary serous adenocarcinoma of the ovary
- (2013) Chel Hun Choi et al. HUMAN PATHOLOGY
- MRP2 (ABCC2, cMOAT) expression in nuclear envelope of primary fallopian tube cancer cells is a new unfavorable prognostic factor
- (2012) Agnieszka Halon et al. ARCHIVES OF GYNECOLOGY AND OBSTETRICS
- Annexin A4 is a possible biomarker for cisplatin susceptibility of malignant mesothelioma cells
- (2012) Takuya Yamashita et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Cancer treatment and survivorship statistics, 2012
- (2012) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- The role of annexin A3 playing in cancers
- (2012) Na Wu et al. Clinical & Translational Oncology
- First-line Chemotherapy in Epithelial Ovarian Cancer
- (2012) MICHAEL A. BOOKMAN CLINICAL OBSTETRICS AND GYNECOLOGY
- New Strategies Against Prostate Cancer – Pt(II)-Based Chemotherapy
- (2012) C. S. Matos et al. CURRENT MEDICINAL CHEMISTRY
- Lessons from mathematically modeling the NF-κB pathway
- (2012) Soumen Basak et al. IMMUNOLOGICAL REVIEWS
- The Annexin A2/S100A10 System in Health and Disease: Emerging Paradigms
- (2012) Nadia Hedhli et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- Carboplatin- or Cisplatin-Based Chemotherapy in First-Line Treatment of Small-Cell Lung Cancer: The COCIS Meta-Analysis of Individual Patient Data
- (2012) Antonio Rossi et al. JOURNAL OF CLINICAL ONCOLOGY
- Akt/mTOR signaling pathway is crucial for gemcitabine resistance induced by Annexin II in pancreatic cancer cells
- (2012) Shingo Kagawa et al. JOURNAL OF SURGICAL RESEARCH
- Perioperative chemotherapy for upper tract urothelial cancer
- (2012) Ajjai S. Alva et al. Nature Reviews Urology
- Extracellular Release of Annexin II From Pancreatic Cancer Cells and Resistance to Anticancer Drug–Induced Apoptosis by Supplementation of Recombinant Annexin II
- (2012) Tetsuo Sato et al. PANCREAS
- Role of multidrug resistance protein 2 (MRP2) in chemoresistance and clinical outcome in oesophageal squamous cell carcinoma
- (2011) M Yamasaki et al. BRITISH JOURNAL OF CANCER
- Secretion of annexin A3 from ovarian cancer cells and its association with platinum resistance in ovarian cancer patients
- (2011) Jie Yin et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Comparative proteomic and radiobiological analyses in human lung adenocarcinoma cells
- (2011) Rui Wei et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Molecular mechanisms of cisplatin resistance
- (2011) L Galluzzi et al. ONCOGENE
- Increased Expression of Annexin A3 Is a Mechanism of Platinum Resistance in Ovarian Cancer
- (2010) X. Yan et al. CANCER RESEARCH
- Annexin A4 interacts with the NF-κB p50 subunit and modulates NF-κB transcriptional activity in a Ca2+-dependent manner
- (2010) Young-Joo Jeon et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Targeting annexin A4 to counteract chemoresistance in clear cell carcinoma of the ovary
- (2010) Ayako Kim et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Annexin IV is Differentially Expressed in Clear Cell Carcinoma of the Ovary
- (2010) Yi Miao et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Therapeutic Targeting of ATP7B in Ovarian Carcinoma
- (2009) L. S. Mangala et al. CLINICAL CANCER RESEARCH
- Enhanced expression of Annexin A4 in clear cell carcinoma of the ovary and its association with chemoresistance to carboplatin
- (2009) Ayako Kim et al. INTERNATIONAL JOURNAL OF CANCER
- Are RAS mutations predictive markers of resistance to standard chemotherapy?
- (2009) Yohann Loriot et al. Nature Reviews Clinical Oncology
- Altered localisation of the copper efflux transporters ATP7A and ATP7B associated with cisplatin resistance in human ovarian carcinoma cells
- (2008) Ganna V Kalayda et al. BMC CANCER
- Role of copper transporters in resistance to platinating agents
- (2008) Cara A. Rabik et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Expression and Prognostic Relevance of Annexin A3 in Prostate Cancer
- (2008) Jens Köllermann et al. EUROPEAN UROLOGY
- The role of annexins in tumour development and progression
- (2008) S Mussunoor et al. JOURNAL OF PATHOLOGY
- Quantitative proteome analysis reveals annexin A3 as a novel biomarker in lung adenocarcinoma
- (2008) YF Liu et al. JOURNAL OF PATHOLOGY
- Proteome Analysis of Membrane Fractions in Colorectal Carcinomas by Using 2D-DIGE Saturation Labeling
- (2008) Patricia Alfonso et al. JOURNAL OF PROTEOME RESEARCH
- Annexin A4: A novel molecular marker for gastric cancer withHelicobacter pylori infection using proteomics approach
- (2008) Li-Ling Lin et al. Proteomics Clinical Applications
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started